Eric Skaar

August 6, 2015

Skaar receives American Asthma Foundation award

Eric Skaar, Ph.D., MPH, the Ernest W. Goodpasture Professor of Pathology, has received a Scholar Award from the American Asthma Foundation (AAF).

By Leigh MacMillan

March 19, 2015

Skaar elected to American Academy of Microbiology

By Bill Snyder

December 4, 2014

Physician-scientist is dream job for Vanderbilt’s Cassat

Jim Cassat, M.D., Ph.D., a pediatric infectious disease specialist who joined the Vanderbilt faculty this summer, loves taking care of children with bone infections and doing research to understand the host-pathogen interactions during these invasive infections.

By Leigh MacMillan

October 16, 2014

Staph ‘gangs’ share nutrients during infection: study

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.

By Leigh MacMillan

April 15, 2014

Anthrax bacteria’s signaling systems

Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.

By Leigh MacMillan

June 20, 2013

Studies outline new model for staph bone infections

Osteomyelitis, a debilitating bone infection most frequently caused by Staphylococcus aureus (“staph”) bacteria, is particularly challenging to treat.

By Leigh MacMillan

February 21, 2013

Antibacterial protein’s molecular workings revealed

Vanderbilt investigators report new insights to the workings of calprotectin, an immune system protein that “starves” bacterial pathogens of the metal nutrients they require.

By Leigh MacMillan

January 17, 2013

Zinc: a new antibiotic target?

It may be possible to fight hospital-acquired pathogens like Acinetobacter baumannii by targeting the bacterium’s need for the nutrient metal zinc.

By Leigh MacMillan

August 9, 2012

Team creates new view of body’s infection response

A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.